Egaten (triclabendazole) is a small molecule pharmaceutical. Triclabendazole was first approved as Egaten on 2019-02-13. It is used to treat fascioliasis in the USA.
Trade Name |
Egaten |
Common Name |
Triclabendazole |
Indication |
fascioliasis |
Drug Class |
Anthelmintics (tibendazole type) |